custirsen   Click here for help

GtoPdb Ligand ID: 14714

Synonyms: ISIS 112989 | ISIS-112989 | ISIS112989 | OGX-011 | OGX011
Compound class: Nucleic acid
Comment: Custirsen (OGX-011) is an antisense oligonucleotide (ASO) that reduces the production of clusterin (CLU; a cytoprotective chaperone protein), by hybridising with clusterin mRNA [4]. This mechanism is intended to re-sensitise tumour cells to chemotherapy and hormone therapy [1-3,5].
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1=CN([C@H]2[C@@H]([C@@H]([C@@H](CO)O2)OP(=S)(O)OC[C@@H]3[C@H]([C@H]([C@H](N4C=NC5=C4N=CN=C5N)O3)OCCOC)OP(=S)(O)OC[C@@H]6[C@H]([C@H]([C@H](N7C=NC8=C7N=C(N)NC8=O)O6)OCCOC)OP(=S)(O)OC[C@@H]9[C@H]([C@H]([C@H](N%10C=C(C)C(=NC%10=O)N)O9)OCCOC)OP(=S)(O)OC[C@@H]%11[C@H](C[C@H](N%12C=NC%13=C%12N=CN=C%13N)O%11)OP(=S)(O)OC[C@@H]%14[C@H](C[C@H](N%15C=NC%16=C%15N=C(N)NC%16=O)O%14)OP(=S)(O)OC[C@@H]%17[C@H](C[C@H](N%18C=CC(=NC%18=O)N)O%17)OP(=S)(O)OC[C@@H]%19[C@H](C[C@H](N%20C=NC%21=C%20N=CN=C%21N)O%19)OP(=S)(O)OC[C@@H]%22[C@H](C[C@H](N%23C=NC%24=C%23N=C(N)NC%24=O)O%22)OP(=S)(O)OC[C@@H]%25[C@H](C[C@H](N%26C=NC%27=C%26N=CN=C%27N)O%25)OP(=S)(O)OC[C@@H]%28[C@H](C[C@H](N%29C=NC%30=C%29N=C(N)NC%30=O)O%28)OP(=S)(O)OC[C@@H]%31[C@H](C[C@H](N%32C=C(C)C(=O)NC%32=O)O%31)OP(=S)(O)OC[C@@H]%33[C@H](C[C@H](N%34C=CC(=NC%34=O)N)O%33)OP(=S)(O)OC[C@@H]%35[C@H](C[C@H](N%36C=C(C)C(=O)NC%36=O)O%35)OP(=S)(O)OC[C@@H]%37[C@H](C[C@H](N%38C=C(C)C(=O)NC%38=O)O%37)OP(=S)(O)OC[C@@H]%39[C@H](C[C@H](N%40C=CC(=NC%40=O)N)O%39)OP(=S)(O)OC[C@@H]%41[C@H](C[C@H](N%42C=NC%43=C%42N=CN=C%43N)O%41)OP(=S)(O)OC[C@@H]%44[C@H]([C@H]([C@H](N%45C=C(C)C(=O)NC%45=O)O%44)OCCOC)OP(=S)(O)OC[C@@H]%46[C@H]([C@H]([C@H](N%47C=C(C)C(=NC%47=O)N)O%46)OCCOC)OP(=O)(OC[C@@H]%48[C@H]([C@H]([C@H](N%49C=NC%50=C%49N=CN=C%50N)O%48)OCCOC)OP(=S)(O)OC[C@@H]%51[C@H]([C@H]([C@H](N%52C=C(C)C(=O)NC%52=O)O%51)OCCOC)O)S)OCCOC)C(=O)N=C1N
Isomeric SMILES CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=S)(O)O[C@H]3C[C@@H](O[C@@H]3COP(=S)(O)O[C@H]4C[C@@H](O[C@@H]4COP(=S)(O)O[C@H]5C[C@@H](O[C@@H]5COP(=S)(O)O[C@H]6C[C@@H](O[C@@H]6COP(=S)(O)O[C@H]7C[C@@H](O[C@@H]7COP(=S)(O)O[C@H]8C[C@@H](O[C@@H]8COP(=S)(O)O[C@H]9C[C@@H](O[C@@H]9COP(=S)(O)O[C@H]%10C[C@@H](O[C@@H]%10COP(=S)(O)O[C@H]%11C[C@@H](O[C@@H]%11COP(=S)(O)O[C@@H]%12[C@H](O[C@H]([C@@H]%12OCCOC)N%13C=C(C(=NC%13=O)N)C)COP(=S)(O)O[C@@H]%14[C@H](O[C@H]([C@@H]%14OCCOC)N%15C=NC%16=C%15N=C(NC%16=O)N)COP(=S)(O)O[C@@H]%17[C@H](O[C@H]([C@@H]%17OCCOC)N%18C=NC%19=C(N=CN=C%19%18)N)COP(=S)(O)O[C@@H]%20[C@H](O[C@H]([C@@H]%20OCCOC)N%21C=C(C(=NC%21=O)N)C)CO)N%22C=NC%23=C(N=CN=C%23%22)N)N%24C=NC%25=C%24N=C(NC%25=O)N)N%26C=CC(=NC%26=O)N)N%27C=NC%28=C(N=CN=C%28%27)N)N%29C=NC%30=C%29N=C(NC%30=O)N)N%31C=NC%32=C(N=CN=C%32%31)N)N%33C=NC%34=C%33N=C(NC%34=O)N)N%35C=C(C(=O)NC%35=O)C)N%36C=CC(=NC%36=O)N)OP(=S)(O)OC[C@@H]%37[C@H](C[C@@H](O%37)N%38C=C(C(=O)NC%38=O)C)OP(=S)(O)OC[C@@H]%39[C@H](C[C@@H](O%39)N%40C=CC(=NC%40=O)N)OP(=S)(O)OC[C@@H]%41[C@H](C[C@@H](O%41)N%42C=NC%43=C(N=CN=C%43%42)N)OP(=S)(O)OC[C@@H]%44[C@H]([C@H]([C@@H](O%44)N%45C=C(C(=O)NC%45=O)C)OCCOC)OP(=S)(O)OC[C@@H]%46[C@H]([C@H]([C@@H](O%46)N%47C=C(C(=NC%47=O)N)C)OCCOC)OP(=O)(OC[C@@H]%48[C@H]([C@H]([C@@H](O%48)N%49C=NC%50=C(N=CN=C%50%49)N)OCCOC)OP(=S)(O)OC[C@@H]%51[C@H]([C@H]([C@@H](O%51)N%52C=C(C(=O)NC%52=O)C)OCCOC)O)S
InChI InChI=1S/C231H312N78O119P20S20/c1-97-52-295(224(324)273-181(97)235)210-174(361-32-24-353-10)166(118(60-310)401-210)422-444(347,464)383-78-136-171(179(366-37-29-358-15)215(406-136)308-95-265-160-189(243)253-86-259-195(160)308)427-448(351,468)387-80-138-172(180(367-38-30-359-16)216(408-138)309-96-269-164-199(309)279-220(247)283-208(164)320)428-447(350,467)385-76-134-168(175(362-33-25-354-11)211(403-134)296-53-98(2)182(236)274-225(296)325)423-442(345,462)380-73-131-114(48-151(397-131)303-90-263-158-187(241)251-84-257-193(158)303)417-439(342,459)379-72-128-115(49-152(398-128)304-91-266-161-196(304)276-217(244)280-205(161)317)418-435(338,455)370-63-121-107(41-144(390-121)291-22-19-141(234)272-223(291)323)411-430(333,450)374-67-125-111(45-148(394-125)300-87-260-155-184(238)248-81-254-190(155)300)415-437(340,457)378-71-130-117(51-154(400-130)306-93-268-163-198(306)278-219(246)282-207(163)319)420-440(343,460)376-68-126-112(46-149(395-126)301-88-261-156-185(239)249-82-255-191(156)301)416-438(341,458)377-70-129-116(50-153(399-129)305-92-267-162-197(305)277-218(245)281-206(162)318)419-436(339,456)373-66-124-109(43-146(393-124)293-56-101(5)201(313)285-228(293)328)413-433(336,453)368-61-119-105(39-142(388-119)289-20-17-139(232)270-221(289)321)409-429(332,449)371-64-122-110(44-147(391-122)294-57-102(6)202(314)286-229(294)329)414-434(337,454)372-65-123-108(42-145(392-123)292-55-100(4)200(312)284-227(292)327)412-432(335,452)369-62-120-106(40-143(389-120)290-21-18-140(233)271-222(290)322)410-431(334,451)375-69-127-113(47-150(396-127)302-89-262-157-186(240)250-83-256-192(157)302)421-441(344,461)382-75-133-167(177(364-35-27-356-13)213(405-133)299-59-104(8)204(316)288-231(299)331)424-445(348,465)384-77-135-169(176(363-34-26-355-12)212(404-135)297-54-99(3)183(237)275-226(297)326)425-446(349,466)386-79-137-170(178(365-36-28-357-14)214(407-137)307-94-264-159-188(242)252-85-258-194(159)307)426-443(346,463)381-74-132-165(311)173(360-31-23-352-9)209(402-132)298-58-103(7)203(315)287-230(298)330/h17-22,52-59,81-96,105-138,142-154,165-180,209-216,310-311H,23-51,60-80H2,1-16H3,(H,332,449)(H,333,450)(H,334,451)(H,335,452)(H,336,453)(H,337,454)(H,338,455)(H,339,456)(H,340,457)(H,341,458)(H,342,459)(H,343,460)(H,344,461)(H,345,462)(H,346,463)(H,347,464)(H,348,465)(H,349,466)(H,350,467)(H,351,468)(H2,232,270,321)(H2,233,271,322)(H2,234,272,323)(H2,235,273,324)(H2,236,274,325)(H2,237,275,326)(H2,238,248,254)(H2,239,249,255)(H2,240,250,256)(H2,241,251,257)(H2,242,252,258)(H2,243,253,259)(H,284,312,327)(H,285,313,328)(H,286,314,329)(H,287,315,330)(H,288,316,331)(H3,244,276,280,317)(H3,245,277,281,318)(H3,246,278,282,319)(H3,247,279,283,320)/t105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118+,119+,120+,121+,122+,123+,124+,125+,126+,127+,128+,129+,130+,131+,132+,133+,134+,135+,136+,137+,138+,142+,143+,144+,145+,146+,147+,148+,149+,150+,151+,152+,153+,154+,165+,166+,167+,168+,169+,170+,171+,172+,173+,174+,175+,176+,177+,178+,179+,180+,209+,210+,211+,212+,213+,214+,215+,216+,429?,430?,431?,432?,433?,434?,435?,436?,437?,438?,439?,440?,441?,442?,443?,444?,445?,446?,447?,448?/m0/s1
InChI Key RCFZILUHCNXXFY-DEDWCYLFSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
Custirsen (OGX-011) was progressed as a clinical candidate for its potential use as an adjunct in cancer therapy. As of October 2026 there were no active trials registered with ClinicalTrials.gov.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT01188187 Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer Phase 3 Interventional Achieve Life Sciences
NCT01630733 A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer Phase 3 Interventional Achieve Life Sciences
NCT01578655 Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer Phase 3 Interventional Achieve Life Sciences